Literature DB >> 6779328

High dose diazepam in schizophrenia.

H Beckmann, S Haas.   

Abstract

The pharmacological properties and the equivocal antipsychotic effects of diazepam reported in the literature suggested the use of high doses of this drug on schizophrenic patients to re-evaluate its usefulness. Treatment of 15 schizophrenic patients with doses of up to 400 mg/day showed a specific effect on hallucinations and certain forms of delusion. One group (nine patients with paranoid-hallucinatory and one with schizo-affective psychosis) showed a significant reduction in psychopathology as documented in the Brief Psychiatric Rating Scale (BPRS) and the Global Clinical Impressions (GCI), whereas five other patients (all of the schizo-affective type with symptoms of depression, euphoria, and/or psychotic anxiety) did not respond and had to be withdrawn from the study. Under the treatment an absence of sedative effects and a development of the feeling of well-being and euphoria were noticed. In three patients with doses of over 260 mg/day a marked loss of inhibitions in sexual and social behaviour was observed. It is concluded that high doses of diazepam may be useful in certain types of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779328     DOI: 10.1007/bf00433257

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

1.  COMPARATIVE CHEMOTHERAPEUTIC TRIAL IN TREATMENT OF CHRONIC BORDERLINE PATIENTS.

Authors:  M I VILKIN
Journal:  Am J Psychiatry       Date:  1964-04       Impact factor: 18.112

2.  Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study.

Authors:  R Kellner; R M Wilson; M D Muldawer; D Pathak
Journal:  Arch Gen Psychiatry       Date:  1975-10

3.  Treatment of chronic hallucinations with diazepam and phenothiazines.

Authors:  J C Kramer
Journal:  Dis Nerv Syst       Date:  1967-09

4.  The schizophrenias as nervous types.

Authors:  G Claridge
Journal:  Br J Psychiatry       Date:  1972-07       Impact factor: 9.319

5.  [Management of chronic schizophrenias using Valium].

Authors:  A Baliarda
Journal:  Schweiz Arch Neurol Neurochir Psychiatr       Date:  1969

6.  "Valium" in the treatment of schizophrenia.

Authors:  B M Irvine
Journal:  Med J Aust       Date:  1969-06-28       Impact factor: 7.738

7.  [Temporary mental after-effects in long-term treatment of tetanus with diazepam (Valium)].

Authors:  W Haider; C Tschakaloff
Journal:  Anaesthesist       Date:  1970-05       Impact factor: 1.041

8.  Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam.

Authors:  T Duka; M Wüster; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

9.  Diazepam-induced release of opioid activity in the rat brain.

Authors:  M Wüster; T Duka; A Herz
Journal:  Neurosci Lett       Date:  1980-03       Impact factor: 3.046

  9 in total
  10 in total

1.  The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients.

Authors:  C Gramsch; H M Emrich; S John; S Haas; H Beckmann; M Zaudig; D von Zerssen
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

Review 2.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

3.  Beneficial effect of high-dose clotiazepam on intractable auditory hallucinations in chronic schizophrenic patients. An open trial.

Authors:  I Jibiki; N Yamaguchi; F Momonoi
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  A controlled evaluation of inpatient crisis treatment for acute schizophrenic episodes.

Authors:  M Olfson; G S Plotke; C M Harding; J Jones; V W Mayfield
Journal:  Psychiatr Q       Date:  1990

5.  High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.

Authors:  A Weizman; S Tyano; H Wijsenbeek; M Ben David
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Prophylactic effect of neuroleptics in symptom-free schizophrenics.

Authors:  T Nishikawa; A Tsuda; M Tanaka; I Koga; Y Uchida
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Hippocampal benzodiazepine receptors in schizophrenia.

Authors:  G P Reynolds; D Stroud
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 8.  Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin?

Authors:  M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

9.  High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients.

Authors:  J N Nestoros; N P Nair; J R Pulman; G Schwartz; D Bloom
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?

Authors:  R L Singhal; R B Rastogi; Y D Lapierre
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.